Rather than representing an unsafe signaling profile, oxyntomodulins dual agonism can be understood as a naturally evolved strategy for coordinated metabolic control
Side Effect Profiles Gastrointestinal symptoms are common with GLP-1 and GIP therapies, but the frequency and severity can vary between MariTide, Wegovy, and Zepbound
Long acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimers disease dementia
Furthermore, mitochondrial dysfunction, neuroinflammation, and oxidative stress are central to biochemical events in PD such as S aggregation, dysregulated sirtuin activity, and impaired insulin signaling (Picca et al., 2020)
Glucagon-like peptide-1 receptor agonists, often referred to simply as GLP-1s, are used to treat type 2 diabetes, overweight, obesity, and more
The clinical sweet spot for most people sits around 10 mg, with 15 mg reserved for those who plateau